Tirzepatide &
Retatutide
ORIVION is a clean, clinically styled line focused on straightforward dosing and clear instructions. Premium products, minimalist standard.
Tirzepatide 10 MG
Selective Dual Incretin
Tirzepatide 30 MG
GLP-1 & GIP Dual Agonist
Retatutide 10 MG
Triple Hormone Mimetic
Retatutide 30 MG
Multi-Receptor Tri-Agonist
About ORIVION Laboratories
ORIVION operates at the forefront of biochemical research, specializing in the synthesis, purification, and structural verification of high-purity research peptides. Our mission is rooted in providing the scientific community with highly consistent reference materials that ensure reproducible data in in-vitro and analytical laboratory settings.
Every batch undergoes rigorous quality control protocols. Utilizing state-of-the-art High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), we guarantee an absolute purity standard of ≥99%. Our manufacturing pipelines strictly adhere to sterile laboratory environments, eliminating cross-contamination and preserving compound stability.
Compliance & Quality Standards
Purity Verified (≥99%)
Validated via certified HPLC & Mass Spectrometry analysis for every single batch.
cGMP Compliant
Synthesized in accordance with Current Good Manufacturing Practice regulations.
ISO 9001:2015
Certified quality management systems ensuring full traceability of raw materials.
Lyophilization Standard
Advanced freeze-drying techniques deployed to maximize peptide shelf-life and potency.
Product Specifications
Official medical and dosing guidelines transcribed directly from product leaflets.
Tirzepatide 10mg
Indications and Usage
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
Dosage and Administration
Box contains: 1x Tirzepatide 10mg (unconstituted) and 1x Bacteriostatic water for injection 3mL. You need 1mL (100u) insulin type syringes with fixed needles 29–30g 0.5mm.
How to Reconstitute
Remove both caps to the vials, insert the needle into the Bacteriostatic water vial, remove 0.80mL (80u) of water from the vial and slowly inject into the Tirzepatide vial. Allow to mix naturally, once reconstituted store below 4°C. DO NOT SHAKE.
Dosage
Every 20u (20 units) or 0.2mL on the syringe is 2.5mg Tirzepatide. The recommended starting dosage is 2.5mg/0.2mL injected subcutaneously once weekly. After 4 weeks, increase to 5mg/0.4mL injected subcutaneously once weekly. If additional glycemic control is needed, increase the dosage in 2.5mg/0.1mL increments. The maximum recommended dosage is 15mg subcutaneously once weekly. Most patients tend to stay on around 5mg once weekly with excellent results.
Administration
Administer once weekly at any time of day, with or without meals. Inject subcutaneously in the abdomen, thigh, or upper arm. Recommended to rotate injection sites with each administration.
Tirzepatide 30mg
Indications and Usage
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
Dosage and Administration
Box contains: 1x Tirzepatide 30mg (unconstituted) and 1x Bacteriostatic water for injection 3mL. You need 1mL (100u) insulin type syringes with fixed needles 29–30g 0.5mm.
How to Reconstitute
Remove both caps to the vials, insert the needle into the Bacteriostatic water vial, remove 1.2mL (120u) of water from the vial and slowly inject into the Tirzepatide vial. Allow to mix naturally, once reconstituted store below 4°C. DO NOT SHAKE.
Dosage
Every 10u (10 units) or 0.1mL on the syringe is 2.5mg Tirzepatide. The recommended starting dosage is 2.5mg/0.1mL injected subcutaneously once weekly. After 4 weeks, increase to 5mg/0.2mL injected subcutaneously once weekly. If additional glycemic control is needed, increase the dosage in 2.5mg/0.1mL increments. The maximum recommended dosage is 15mg subcutaneously once weekly. Most patients tend to stay on around 5mg once weekly with excellent results.
Administration
Administer once weekly at any time of day, with or without meals. Inject subcutaneously in the abdomen, thigh, or upper arm. Recommended to rotate injection sites with each administration.
Retatrutide 10mg
Indications and Usage
Retatrutide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
Dosage and Administration
Box contains: 1x Retatrutide 10mg (unconstituted) and 1x Bacteriostatic water for injection 3mL. You need 1mL (100u) insulin type syringes with fixed needles 29–30g 0.5mm.
How to Reconstitute
Remove both caps to the vials, insert the needle into the Bacteriostatic water vial, remove 0.80mL (80u) of water from the vial and slowly inject into the Retatrutide vial. Allow to mix naturally, once reconstituted store below 4°C. DO NOT SHAKE.
Dosage
Every 20u (20 units) or 0.2mL on the syringe is 2.5mg Retatrutide. The recommended starting dosage is 2.5mg/0.2mL injected subcutaneously once weekly. After 4 weeks, increase to 5mg/0.4mL injected subcutaneously once weekly. If additional glycemic control is needed, increase the dosage in 2.5mg/0.1mL increments. The maximum recommended dosage is 15mg subcutaneously once weekly. Most patients tend to stay on around 5mg once weekly with excellent results.
Administration
Administer once weekly at any time of day, with or without meals. Inject subcutaneously in the abdomen, thigh, or upper arm. Recommended to rotate injection sites with each administration.
Retatrutide 30mg
Indications and Usage
Retatrutide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
Dosage and Administration
Box contains: 1x Retatrutide 30mg (unconstituted) and 1x Bacteriostatic water for injection 3mL. You need 1mL (100u) insulin type syringes with fixed needles 29–30g 0.5mm.
How to Reconstitute
Remove both caps to the vials, insert the needle into the Bacteriostatic water vial, remove 1.2mL (120u) of water from the vial and slowly inject into the Retatrutide vial. Allow to mix naturally, once reconstituted store below 4°C. DO NOT SHAKE.
Dosage
Every 10u (10 units) or 0.1mL on the syringe is 2.5mg Retatrutide. The recommended starting dosage is 2.5mg/0.1mL injected subcutaneously once weekly. After 4 weeks, increase to 5mg/0.2mL injected subcutaneously once weekly. If additional glycemic control is needed, increase the dosage in 2.5mg/0.1mL increments. The maximum recommended dosage is 15mg subcutaneously once weekly. Most patients tend to stay on around 5mg once weekly with excellent results.
Administration
Administer once weekly at any time of day, with or without meals. Inject subcutaneously in the abdomen, thigh, or upper arm. Recommended to rotate injection sites with each administration.
DISCLAIMER: All products listed on this website are strictly for research purposes only and are not intended for human consumption, therapeutic, or diagnostic use. These products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. By purchasing from ORIVION, you acknowledge and agree that these substances are handled solely for laboratory and analytical applications by qualified professionals.